In December 2019, TargetCancer Foundation announced $240,000 in new cholangiocarcinoma grant funding. The following post was written by Grant Recipient Nabeel...
Today TargetCancer Foundation remembers our founder, Paul Poth, whose life was taken by cholangiocarcinoma at age 39 on this day ten years ago- August 22,...
By TargetCancer Foundation 2019 Summer Intern Ollie Cheever The fifth annual Matt Lindsay Memorial Golf Tournament tees off this Saturday, August 3rd, at the...
By Alie Plouff, TargetCancer Foundation Advocacy Council Member Like many things in life, grief isn’t black and white. In fact, it is mostly one large gray...
By Leslie Condon, TargetCancer Foundation Advocacy Council Chair The National Organization for Rare Disorders was formed after a small coalition of rare...
We are happy to announce that Team TargetCancer Foundation will be making its fifth appearance in the Boston Marathon in 2019! We are excited to return to...
Did you know that Facebook makes it incredibly easy to engage your community to raise funds for TargetCancer Foundation? You can create a fundraiser to...
We are tremendously proud to announce the launch of the Gastroesophageal Cancer Project, a new, innovative patient partnered research initiative. The...
By TargetCancer Foundation Advocacy Council Chair Leslie Condon When I walked into McCormick Place on the first day of this year’s annual ASCO Conference, I...
By Guest Blogger Dana Deighton Though my 25 years of professional experiences are mostly rooted in marketing, the last 15 years or so of my personal life have...
Clinical trials are a critical part of the development of new treatments. They rely on people who volunteer to participate and are then closely monitored by...
As our programs at TargetCancer Foundation continue to expand, we remain committed to our primary mission of funding innovative rare cancer research. We are...
By Karen Dempsey, TargetCancer Foundation Advocacy Council Member Though researchers classify cholangiocarcinoma as a rare cancer, we know the reach of the...
Earlier this week, TargetCancer Foundation joined with the National Organization of Rare Disorders (NORD) and 81 other rare advocacy organizations to express...
By Kim Balkus, TargetCancer Foundation Advocacy Council Member Writing a blog post after attending the 2018 Cholangiocarcinoma Foundation Annual Conference...